N. E. Basci Et Al. , "S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.," British Journal of Clinical Pharmacology , vol.38, no.5, pp.463-465, 1994
Basci, N. E. Et Al. 1994. S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.. British Journal of Clinical Pharmacology , vol.38, no.5 , 463-465.
Basci, N. E., Brosen, K., Bozkurt, A., Isimer, A., Sayal, A., & Kayaalp, S., (1994). S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.. British Journal of Clinical Pharmacology , vol.38, no.5, 463-465.
Basci, NURSABAH Et Al. "S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.," British Journal of Clinical Pharmacology , vol.38, no.5, 463-465, 1994
Basci, NURSABAH E. Et Al. "S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.." British Journal of Clinical Pharmacology , vol.38, no.5, pp.463-465, 1994
Basci, N. E. Et Al. (1994) . "S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.." British Journal of Clinical Pharmacology , vol.38, no.5, pp.463-465.
@article{article, author={NURSABAH ELİF BAŞCI AKDUMAN Et Al. }, title={S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.}, journal={British Journal of Clinical Pharmacology}, year=1994, pages={463-465} }